BioSpace News Archive

Business

Alnylam, Beam and More Launch New RNA Player Orbital Tx

Orbital Therapeutics, co-founded by John Maraganore, launched with the goal of harnessing the full potential of RNA-based therapeutics to tackle diseases in a new and more effective manner.

September 7, 2022
·
3 min read
·
Alex Keown
Global Roundup: Zealand Pharma and Novo Nordisk Headline Cross-Continental Collaborations

Zealand Pharma and Novo Nordisk linked resources to commercialize Zegalogue for severe hypoglycemia. For that and more from a busy week across the globe, see inside.

September 7, 2022
·
5 min read
·
Alex Keown
Drug Development

FDA Adcomm Backs Amylyx ALS Drug in Rare Second Vote

Wednesday evening, the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee voted 7-2 to recommend approval of Amylyx ALS candidate AMX0035.

September 7, 2022
·
4 min read
·
Alex Keown
Business

Ionis, AstraZeneca Report Promising Late-Stage Data for ATTR Antisense Candidate

Preliminary findings from the NEURO-TTRansform trial show Ionis’ and AstraZeneca’s eplontersen is potentially a safe and effective treatment for patients with amyloidosis.

September 7, 2022
·
3 min read
·
Tristan Manalac
Deals

Acquisitive Roche, Equillium Sink Funds into IL-2 and GI Drugs

Roche acquired privately held Good Therapeutics and its immuno-oncology platforms for $250 million, and Equillium acquired Metacrine and its GI platform in an all-stock deal.

September 7, 2022
·
1 min read
·
Paul Elias
Career Advice

How to Make the Most of Your Life Science Internship

Landing your first internship can be a major milestone in your career journey. Here’s what you can do to set yourself up for success and make the most of your life science internship.

September 7, 2022
·
4 min read
·
Franklin Carpenter
Business

FDA Job Cuts Loom with Partisan Lock in Congress - Updated

Thousands of FDA employees may lose their jobs if Congress doesn’t reappropriate funding currently in place by the end of the month.

September 7, 2022
·
3 min read
·
Tristan Manalac
Business

Money on the Move: Arcutis Acquires Ducentis and a Hefty Gift to UCSD (Updated)

Arcutis scoops up Ducentis and its lead asset DS-234, UC San Diego receives $150M earmarked for stem cell, regenerative medicine research and Arsenal and ILiAD reel in new funds.

September 7, 2022
·
3 min read
·
Tristan Manalac
Business

Accuray Partners with Swiss-based Genolier Innovation Hub to Bring Medical and Technological Advances to Patients Faster

Accuray Incorporated announced the company is joining forces with Genolier Innovation Hub, a fully-owned subsidiary of AEVIS VICTORIA SA, in support of a unique new approach to improving patient care.

September 7, 2022
·
6 min read
Deals

Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio

AcuraBio, a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, a global healthcare private equity firm.

September 7, 2022
·
3 min read